Magsorbeo Biomedical Corp. — Form D
Magsorbeo Biomedical Corp. of NEWARK, DE, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-21. The offering totals $25K, of which $25K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-21
- Form: D
- Accession: 0001958753-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25K
- Amount sold: $25K
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2022-12-15
- Revenue range: Decline to Disclose
- SEC file number: 021-468298
Issuer
- Name: Magsorbeo Biomedical Corp.
- CIK: 0001958753
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 254 CHAPMAN RD, NEWARK, DE, 19702
- Phone: 231-329-1259
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Leann Christman | Director | Ann Arbor, MI |
| Jacob Edick | Director | Newark, DE |
| Joe Messerly | Director | Newark, DE |
| Carolyn Woldring | Director | East Lansing, MI |
| Jacob Edick | Executive Officer | Newark, DE |
| Anthony Pizzi | Executive Officer | Newark, DE |
More